Cancer Biology & Therapy
Volume 16, 2015 - Issue 2
Open access
1,877
Views
12
CrossRef citations to date
0
Altmetric
Bedside to Bench Reports
Metformin: a modulator of bevacizumab activity in cancer? A case report
Stefano IndraccoloImmunology and Molecular Oncology Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, ItalyCorrespondence[email protected]
, Giovanni RandonMedical Oncology 2 Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
, Elisabetta ZulatoImmunology and Molecular Oncology Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
, Margherita NardinRadiology Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
, Camillo AlibertiRadiology Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
, Fabio PomerriRadiology Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
, Alessandra CasarinMedical Oncology 2 Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
& Maria Ornella NicolettoMedical Oncology 2 Unit; Istituto Oncologico Veneto-IOV-IRCCS; Padova, Italy
show all
Pages 210-214
|
Received 22 Oct 2014, Accepted 18 Dec 2014, Published online: 10 Mar 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.